← Open Payments lookup

JULIA VEGA: Open Payments

NPI 1992180517 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,384 in 66 payments from 21 companies in 2025. Trend: 2023 $1,459 · 2024 $2,062 · 2025 $1,384

Food & beverage: $1,336Education: $48
CompanyPaymentsAmount
PFIZER INC.18$376
Janssen Biotech, Inc.6$159
GENZYME CORPORATION5$143
AstraZeneca Pharmaceuticals LP3$80
Gilead Sciences, Inc.3$66
Celgene Corporation3$55
E.R. Squibb & Sons, L.L.C.3$54
ABBVIE INC.2$50
Exelixis Inc.2$49
Takeda Pharmaceuticals U.S.A., Inc.2$48

Products named: IBRANCE, SARCLISA, Padcev, Trodelvy, TALVEY, REBLOZYL, DARZALEX, VENCLEXTA.

Industry payments across GA — which companies pay providers there.